Silverback Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SBTX and other ETFs, options, and stocks.

About SBTX

Silverback Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. 

CEO
Laura K. Shawver
CEOLaura K. Shawver
Employees
90
Employees90
Headquarters
Seattle, Washington
HeadquartersSeattle, Washington
Founded
2016
Founded2016
Employees
90
Employees90

SBTX Key Statistics

Market cap
190.14M
Market cap190.14M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
202.78K
Average volume202.78K
High today
$5.36
High today$5.36
Low today
$4.91
Low today$4.91
Open price
$4.96
Open price$4.96
Volume
117.46K
Volume117.46K
52 Week high
$11.85
52 Week high$11.85
52 Week low
$2.80
52 Week low$2.80

SBTX Earnings

-$1.37
-$0.91
-$0.46
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 9, After Hours
ActualExpected Nov 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.